Table 1.
Comparison of patient demographics for patients with POAF and NSR following CABG/OPCAB ± AVR in Iceland between 2002 and 2006
| POAF (n = 326) | NSR (n = 418) | p-value | |
|---|---|---|---|
| Male (%) |
244 (74) |
349 (83) |
0.005 |
| Age in years, mean ± SD |
70 ± 9.3 |
64 ± 8.7 |
< 0.001 |
| Diabetes (%) |
62 (19) |
60 (14) |
0.11 |
| Hypertension (%) |
213 (65) |
248 (59) |
0.11 |
| Dyslipidemia (%) |
161 (49) |
263 (63) |
< 0.001 |
| Smoking history (%) |
58 (18) |
111 (35) |
0.005 |
| Chronic heart failure (%) |
66 (20) |
35 (8) |
< 0.001 |
| Mean number of affected vessels |
2.4 |
2.7 |
< 0.001 |
| Mean left ventricular ejection fraction (LVEF) |
51 |
55 |
< 0.001 |
| Mean EuroSCORE |
6.0 |
4.0 |
< 0.001 |
| β blocker use preoperatively (%) |
201 (62) |
291 (70) |
0.074 |
| Ca2+ channel blocker use preoperatively (%) |
67 (21) |
80 (19) |
0.58 |
| Statin use preoperatively (%) | 201 (63) | 316 (76) | < 0.001 |